Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Irinotecan Liposome Injection
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.